Literature DB >> 27265754

Multiple sclerosis: The resolving lesion revealed.

Cedric S Raine1.   

Abstract

A little studied lesion, the resolving lesion, is described in multiple sclerosis (MS). Unusual features of early resolving lesions comprised a fibrous astrogliotic parenchyma replete with lipid-laden (foamy) microglia/macrophages widely scattered throughout and lined up at the edge, separating demyelinated plaque from myelinated white matter. Ongoing myelin breakdown was absent, as was remyelination. Later resolving lesions displayed the unusual coexistence of macrophages and remyelination within the gliotic parenchyma. Collectively, these observations may provide for the first time evidence for a role in MS for mitigating factors like alternatively-activated (M2) microglia/macrophages, known to have an anti-inflammatory phenotype and to be associated with wound-healing and repair.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative activation; Foamy macrophages; Microglia; Multiple sclerosis; Regulatory mechanisms; Remyelination; Resolving plaque

Mesh:

Year:  2016        PMID: 27265754      PMCID: PMC5124553          DOI: 10.1016/j.jneuroim.2016.05.021

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Microglia in Health and Disease.

Authors:  Richard M Ransohoff; Joseph El Khoury
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-09       Impact factor: 10.005

2.  Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.

Authors:  Axel Nimmerjahn; Frank Kirchhoff; Fritjof Helmchen
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

3.  Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis.

Authors:  Leonie A Boven; Marjan Van Meurs; Marloes Van Zwam; Annet Wierenga-Wolf; Rogier Q Hintzen; Rolf G Boot; Johannes M Aerts; Sandra Amor; Edward E Nieuwenhuis; Jon D Laman
Journal:  Brain       Date:  2005-12-19       Impact factor: 13.501

Review 4.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

5.  Pathology of multiple sclerosis.

Authors:  F Seitelberger
Journal:  Ann Clin Res       Date:  1973-10

6.  Multiple sclerosis: remyelination of nascent lesions.

Authors:  J W Prineas; R O Barnard; E E Kwon; L R Sharer; E S Cho
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

7.  Multiple sclerosis. Pathology of recurrent lesions.

Authors:  J W Prineas; R O Barnard; T Revesz; E E Kwon; L Sharer; E S Cho
Journal:  Brain       Date:  1993-06       Impact factor: 13.501

8.  Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.

Authors:  Carol A Colton; Ryan T Mott; Hayley Sharpe; Qing Xu; William E Van Nostrand; Michael P Vitek
Journal:  J Neuroinflammation       Date:  2006-09-27       Impact factor: 8.322

9.  Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.

Authors:  Veela Mehta; Wei Pei; Grant Yang; Suyang Li; Eashwar Swamy; Aaron Boster; Petra Schmalbrock; David Pitt
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

Review 10.  The benefits and detriments of macrophages/microglia in models of multiple sclerosis.

Authors:  Khalil S Rawji; V Wee Yong
Journal:  Clin Dev Immunol       Date:  2013-06-12
  10 in total
  12 in total

Review 1.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

2.  Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target.

Authors:  Insha Zahoor; Hamid Suhail; Indrani Datta; Mohammad Ejaz Ahmed; Laila M Poisson; Jeffrey Waters; Faraz Rashid; Rui Bin; Jaspreet Singh; Mirela Cerghet; Ashok Kumar; Md Nasrul Hoda; Ramandeep Rattan; Ashutosh K Mangalam; Shailendra Giri
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-14       Impact factor: 12.779

3.  Progressive Multiple Sclerosis Transcriptome Deconvolution Indicates Increased M2 Macrophages in Inactive Lesions.

Authors:  Sai Batchu
Journal:  Eur Neurol       Date:  2020-08-28       Impact factor: 1.710

Review 4.  Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia.

Authors:  Stephanie A Amici; Joycelyn Dong; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

5.  Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.

Authors:  Tobias Zrzavy; Simon Hametner; Isabella Wimmer; Oleg Butovsky; Howard L Weiner; Hans Lassmann
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

Review 6.  Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?

Authors:  Min Joung Kim; Jung Hee Kang; Paschalis Theotokis; Nikolaos Grigoriadis; Steven Petratos
Journal:  Cells       Date:  2018-12-20       Impact factor: 6.600

Review 7.  Nanomodulation of Macrophages in Multiple Sclerosis.

Authors:  Frances K Nally; Chiara De Santi; Claire E McCoy
Journal:  Cells       Date:  2019-06-05       Impact factor: 6.600

Review 8.  Resolution of inflammation during multiple sclerosis.

Authors:  F Ruiz; S Vigne; C Pot
Journal:  Semin Immunopathol       Date:  2019-11-15       Impact factor: 9.623

9.  In Vivo Proton Exchange Rate (kex ) MRI for the Characterization of Multiple Sclerosis Lesions in Patients.

Authors:  Haiqi Ye; Mehran Shaghaghi; Qianlan Chen; Yan Zhang; Sarah E Lutz; Weiwei Chen; Kejia Cai
Journal:  J Magn Reson Imaging       Date:  2020-09-24       Impact factor: 4.813

Review 10.  Association of infections with multiple sclerosis in Gulf Cooperation Council countries: a review.

Authors:  O Al Wutayd
Journal:  J Int Med Res       Date:  2019-12-27       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.